To Evaluate The Safety and Efficacy of AVI Stent Comparing With Firebird2® For Treating Coronary Revascularization
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2000 participants.
Also called NCT02133287
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 2,000 participants
- Sponsor
- Beijing AmsinoMed Medical Device Co., Ltd
- Registry
-
NCT02133287
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02133287. Randomized; no masking; primary purpose treatment. Start 2013-08 (actual); primary completion 2018-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- To Evaluate The Safety and Efficacy of 'AVI' Stent Comparing With Firebird2® For Treating Coronary Revascularization
- Condition
- Ischemic Heart Disease
- Condition
- Myocardial Ischemia
- Condition
- Coronary Disease
- Condition
- Acute Coronary Syndrome
- Intervention (Device)
- AVI® Arsenic trioxide drug eluting stent delivery system
- Intervention (Device)
- Firebird2® sirolimus eluting stent system
- Lead sponsor
- Beijing AmsinoMed Medical Device Co., Ltd
Record details
- Record id
cardio:ct-nct02133287- Content hash
03ef12488697becb1459d73ca50a577eae587b685b91539fb2a924930206b3b0